Notizie

Prodotti
IFU
EN-it
EN-it
Casa>Notizie

Introduzione del catetere venoso centrale antimicrobico

2022-07-28
LEPU
Introduzione del catetere venoso centrale antimicrobico

Lepu's Antimicrobial Central Venous Catheter is the first medicated central venous catheter market in China. Since its official launch in 2008, it has been used in millions of clinical cases.



Why It Is Recommended To Use Antimicrobial Central Venous Catheter?

In clinical practice, Kit catetere venoso centrale is commonly used to rescue critically ill patients with severe shock, dehydration, blood loss, and hypovolemia. Monitoring of central venous pressure can guide clinicians in diagnosing and treating patients, so it is often necessary to retain or prolong the indwelling time of the catheter. 


However, the operation time of central venous puncture is short, the patient's body resistance is low, immunity is weak, and trauma is large. With the widespread use of central venous catheters, the consequent infection rate has increased significantly, and the mortality rate of patients has increased. Clinically, central venous catheters have been listed as a common source of infection, so the choice of an Antimicrobial Central Venous Catheter with a bacteriostatic effect can reduce the incidence of infection in patients.


antimicrobial-central-venous-cather-1.jpg



Benefici e vantaggi del catetere venoso centrale antimicrobico medico Lepu

The disposable Antimicrobial Central Venous Catheter produced by Lepu Produttore di attrezzature mediche is based on the traditional central venous catheter and is coated with two antibiotics, rifampicin and minocycline hydrochloride. Among them, rifampicin is a semi-synthetic broad-spectrum antibacterial drug of rifampicin. It has an inhibitory effect on aerobic gram-positive bacteria and aerobic gram-negative bacteria. Minocycline Hydrochloride is a semi-synthetic tetracycline broad-spectrum antibiotic with high efficacy and long-term effect. It has an inhibitory effect on Staphylococcus aureus, Streptococcus, etc., and Gram-negative bacteria. Combining these two drugs produces a complementary antibacterial effect, which can achieve an excellent antibacterial effect. It has been documented that the drug CVC can reduce the incidence of CRABSI by 90%. 


Lepu Medical's Prodotti per cure critiche like the Antimicrobial Central Venous Catheter is available in various sizes and is suitable for different types of patients, providing more options for doctors. The connection between the catheter and the extension tube adopts the patented technology, which has solved the leakage and seepage problems of similar products on the market.



L'uso clinico di cateteri venosi centrali medicati può ridurre significativamente l'incidenza dell'infezione nei pazienti, che è anche una nuova misura preventiva per prevenire complicazioni infettive e controversie mediche non necessarie. Il catetere venoso centrale antimicrobico prodotto da Lepu presenta i vantaggi di una buona progettazione, sicurezza, efficacia, ampio spettro antibatterico, lungo tempo antibatterico, nessuna reazione allergica, può ridurre il ciclo di applicazione degli antibiotici sistemici e ha un alto valore di applicazione clinica.



Per maggiori informazioni:https://en.lepumedical.com/products/safecath-plus-antimicrobial-central-venous-catheter-kit/


Invia